Expert Pitch

What does coronavirus mean for the American workforce?

Cornell University
2-Mar-2020 1:25 PM EST, by Cornell University

CORNELL UNIVERSITY MEDIA RELATIONS OFFICE
March 2, 2020

 

What does coronavirus mean for the American workforce? 

Economic disruption caused by the spread of the coronavirus could impact work in numerous ways – from loss of wages suffered by low-wage workers, to reconfiguration of global job location, to greater dependence on technology to keep employees connected if workplaces are closed due to health concerns.

Alexander Colvin, dean of Cornell University’s ILR School, is a work, labor and employment scholar. Dean Colvin can speak about the impact of the coronavirus on workers and organizations in the global economy. In the latest episode of the podcast “WORK!” he discussed the topic with New York Times economics reporter Eduardo Porter.

Bio: https://www.ilr.cornell.edu/people/alexander-colvin

 

Colvin says:

“When times get tough, it's often the most vulnerable who take the worst hit. Economic slowdown due to the coronavirus will disproportionately impact low-wage workers, who often lack benefits such as paid sick leave.

“This situation could result in some businesses taking stock of whether to place production jobs in developing countries or locating them in developed countries. Calculations about the benefits and costs of moving jobs to different countries adds to uncertainty around the impact of the virus on employment.

“Moving jobs back to the U.S. would come with additional labor costs, but the coronavirus might be a tipping point for some companies considering the return of some jobs to the U.S.

“Technology will become even more central to work if working from home is mandated by more organizations during the coronavirus outbreak. Many workers could experience sustained remote work for the first time in their careers.”

 

For interviews contact:
Rebecca Valli
office: 607-255-6035
cell: 607-793-1025
rv234@cornell.edu

 

 

Cornell University has dedicated television and audio studios available for media interviews supporting full HD, ISDN and web-based platforms.

- 30 -

 




Filters close

Showing results

110 of 2539
Released: 13-Jul-2020 4:05 PM EDT
OADN & AACN Secure No-Cost Access to COVID-19 Screening Solution Until Vaccines Become Widely Available
Organization for Associate Degree Nursing (OADN)

OADN & AACN Secure No-Cost Access to COVID-19 Screening Solution Until Vaccines Become Widely Available

Newswise: Study suggests lymphoma drug acalabrutinib might offer a potential therapeutic approach for severe COVID-19 infection
Released: 13-Jul-2020 3:45 PM EDT
Study suggests lymphoma drug acalabrutinib might offer a potential therapeutic approach for severe COVID-19 infection
Hackensack Meridian Health

The mechanisms of action of acalabrutinib led to the hypothesis it might be effective in reducing the massive inflammatory response seen severe forms of COVID19. Indeed, it did provide clinical benefit in a small group of patients by reducing their inflammatory parameters and improving their oxygenation.

Newswise: National Virtual Biotechnology Laboratory Unites DOE Labs Against COVID-19
Released: 13-Jul-2020 3:40 PM EDT
National Virtual Biotechnology Laboratory Unites DOE Labs Against COVID-19
Department of Energy, Office of Science

To focus its efforts against the COVID-19 pandemic, DOE is bringing the national laboratories together into the National Virtual Biotechnology Laboratory.

Newswise: Key Insights from Swedish Casino that Remained Open During COVID-19
Released: 13-Jul-2020 3:40 PM EDT
Key Insights from Swedish Casino that Remained Open During COVID-19
University of Nevada, Las Vegas (UNLV)

As casinos in Las Vegas enter the second month of reopening since the COVID-19 pandemic took hold, UNLV gaming researchers say they can draw upon insights from industry collaborators in Sweden, a country that took a more open approach to the crisis compared to other governments.

Released: 13-Jul-2020 3:05 PM EDT
Asymptomatic Transmission and Reinfection of COVID: Live Event for July 16, 2PM EDT
Newswise

Emerging data shows more risk of asymptomatic transmission and reinfection with COVID than previously thought. Experts will discuss these findings and what are the implications for managing the pandemic. Media are invited to attend and ask questions.

Released: 13-Jul-2020 2:40 PM EDT
Engineered llama antibodies neutralize COVID-19 virus
Rosalind Franklin Institute

Antibodies derived from llamas have been shown to neutralise the SARS-CoV-2 virus in lab tests, UK researchers announced today.

Released: 13-Jul-2020 1:25 PM EDT
1 in 3 young adults may face severe COVID-19
University of California, San Francisco (UCSF)

As the number of young adults infected with the coronavirus surges throughout the nation, a new study by researchers at UCSF Benioff Children's Hospitals indicates that youth may not shield people from serious disease.

Released: 13-Jul-2020 12:25 PM EDT
Scientists discover key element of strong antibody response to COVID-19
Scripps Research Institute

A team led by scientists at Scripps Research has discovered a common molecular feature found in many of the human antibodies that neutralize SARS-CoV-2, the coronavirus that causes COVID-19.

Released: 13-Jul-2020 11:15 AM EDT
UTHealth joins study of blood pressure medication’s effect on improving COVID-19 outcomes
University of Texas Health Science Center at Houston

An interventional therapy aimed at improving survival chances and reducing the need for critical care treatment due to COVID-19 is being investigated by physicians at The University of Texas Health Science Center at Houston (UTHealth). The clinical trial is underway at Memorial Hermann and Harris Health System’s Lyndon B. Johnson Hospital.


Showing results

110 of 2539

close
3.47927